HomeStocksNRIX

NRIX — structural market context

Nurix Therapeutics, Inc. Commo

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

NRIX short interest & days to cover

SHARES SHORT
18.4M
% OF FLOAT
DAYS TO COVER
18.0
CHANGE VS PRIOR
+2.1%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-07-31 (33d ago)

NRIX fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-08-14 · 19d67$27.19
2026-08-06 · 27d3K$25.12
2026-07-22 · 42d4$23.48

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

NRIX insider buying and selling (Form 4)

Last 12 months, open-market only: 0 purchases · 1 sale

InsiderTypeSharesValueFiled
Hansen Gwenn · officer: Chief Scientific OfficerSell (S)1K$37K2026-09-01

SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.

Frequently asked questions

Are insiders buying NRIX?
In the last 12 months of SEC Form 4 filings, NRIX recorded 0 open-market insider purchases and 1 open-market sale (codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
Is this page telling me to buy or sell NRIX?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.

NRIX Short Interest, Insider Activity & Analyst Context | TradeAI News